BridgeBio Pharma, Inc. — 10-K Filings
7 10-K filings on record
This page lists all 10-K filings submitted to the SEC by BridgeBio Pharma, Inc. (BBIO), sorted by most recent first. Each row links to the full filing on EdgarLookup. BridgeBio Pharma, Inc. has filed 7 10-K documents with the SEC since 2018. To view all SEC filings by BridgeBio Pharma, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
424B7
425
5
5/A
8-A12B
8-K
ARS
CERT
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001743881-26-000009 | Feb 24, 2026 | Dec 31, 2025 |
| 10-K | 10-K | 0000950170-25-024119 | Feb 20, 2025 | Dec 31, 2024 |
| 10-K | 10-K | 0000950170-24-018811 | Feb 22, 2024 | Dec 31, 2023 |
| 10-K | 10-K | 0000950170-23-004145 | Feb 23, 2023 | Dec 31, 2022 |
| 10-K | 10-K | 0000950170-22-002030 | Feb 25, 2022 | Dec 31, 2021 |
| 10-K | 10-K | 0001564590-21-008969 | Feb 25, 2021 | Dec 31, 2020 |
| 10-K | 10-K | 0001564590-20-008260 | Mar 3, 2020 | Dec 31, 2019 |